Multilevel Mobile Health Program to Improve Hypertension Among Midlife Women After Hypertensive Disorder of Pregnancy
Sponsor: University of Pittsburgh
Trial Details
| Condition | Hypertension (HTN), Preeclampsia, Hypertensive Disorders of Pregnancy (HDP) |
| Intervention | Coaching application; Home-based blood pressure monitoring; WebMD |
| Phase | NA |
| Status | Recruiting |
| Participants | 50 |
| Est. Completion | 1 July 2027 |
| Last Updated | 29 July 2026 |
Primary Outcome
Change in systolic blood pressure from baseline to 3 months
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP. * Evidence of current stage 2 HTN (BP ≥ 140/90 mmHg with or without treatment with antihypertensive medication). Exclusion Criteria: * Known clinical CVD (prior myocardial infarction, stroke, heart failure, or peripheral arterial disease). * Males will also be excluded from this study as it focuses on pregnancy related conditions. * Children will be excluded as the study is only recruiting people who are 10-20 years postpartum.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service